Sera Prognostics, Inc. (SERA): Revenue
$81.0K
Year ended 2025-12-31
$70.0K
Trailing 12 months to 2026-06-30
-32.9%
3-year compound annual growth
+26.5%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $81.0K | +5.2% | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | $77.0K | -74.8% | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | $306.0K | +14.2% | 2025-03-19, From 2023-01-01 |
| 2022-12-31 | $268.0K | +226.8% | 2024-03-20, From 2022-01-01 |
| 2021-12-31 | $82.0K | +228.0% | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | $25.0K | n/a | 2022-03-29, From 2020-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Sera Prognostics, Inc. (SERA) | 2025-12-31 | $81.0K | +5.2% |
| Aclarion, Inc. (ACON) | 2025-12-31 | $75.7K | +65.6% |
| YD Bio Ltd (YDES) | 2025-12-31 | $596.8K | +16.9% |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | $7.42M | -21.9% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $28.08M | -0.9% |
| CapForce Inc. (CFOR) | 2025-12-31 | $30.20M | +481.2% |
| Exagen Inc. (XGN) | 2025-12-31 | $66.58M | +19.7% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $69.65M | -17.7% |
| Biodesix Inc (BDSX) | 2025-12-31 | $88.50M | +24.1% |
Compare SERA, ACON, YDES, BGLC side by side · Screen every company in Services-Medical Laboratories ↗